Farabi Pharmaceutical (XTEH:DFRB1) Cash Flow for Dividends: IRR0.00 Mil (TTM As of . 20)


What is Farabi Pharmaceutical Cash Flow for Dividends?

Farabi Pharmaceutical XTEH:DFRB1 Cash Flow for Dividends is IRR0.00 Mil as of . 20.

Farabi Pharmaceutical's cash flow for dividends for the three months ended in . 20 was IRR0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Farabi Pharmaceutical Cash Flow for Dividends Related Terms

Farabi Pharmaceutical Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Cash Flow for Dividends Chart

Farabi Pharmaceutical Annual Data
Trend
Cash Flow for Dividends

Farabi Pharmaceutical Quarterly Data
Cash Flow for Dividends

Farabi Pharmaceutical Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was IRR0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Cash Flow for Dividends of IRR0.00 Mil as of . 20. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Cash Flow for Dividends too high?
Farabi Pharmaceutical's current Cash Flow for Dividends is IRR0.00 Mil.
How does Farabi Pharmaceutical's Cash Flow for Dividends compare to IMNPQ and INNV?
Farabi Pharmaceutical's Cash Flow for Dividends of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Cash Flow for Dividends is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Cash Flow for Dividends of IRR0.00 Mil. The current Cash Flow for Dividends is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Cash Flow for Dividends is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.